// App-Quantinova.ai

C213 : Beta Cell-Specific Free Circulating DNA May Predict the Outcome After Clinical Islet Transplantation.

Researchers

Presenter

  • B. Gala-Lopez

Principal Investigators

  • D. Neiman

  • T. Kin

  • D. O'Gorman

  • A. Pepper

  • A. Malcolm

  • B. Glaser

  • R. Shemer

  • Y. Dor

  • J. Shapiro

Medical Centers

  • Department of Surgery, Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada

  • Department of Developmental Biology and Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  • Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Locations

  • Canada

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • C-peptide

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved